UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial

The lancet oncology, 2018-09, Vol.19 (9), p.1192-1204

2018

Volltextzugriff (PDF)

Late autophagy inhibitor chloroquine improves efficacy of the histone deacetylase inhibitor SAHA and temozolomide in gliomas

Biochemical pharmacology, 2019-05, Vol.163, p.440-450

2019

Volltextzugriff (PDF)

Development of New Nanoniosome Carriers for Vorinostat: Evaluation of Anticancer Efficacy In Vitro

Journal of pharmaceutical sciences, 2024-08, Vol.113 (8), p.2584-2594

2024

Volltextzugriff (PDF)

Epigenetic inhibition assisted chemotherapeutic treatment of lung cancer based on artificial exosomes

Pharmacological research, 2021-09, Vol.171, p.105787, Article 105787

2021

Volltextzugriff (PDF)

In-vivo administration of histone deacetylase inhibitors does not impair natural killer cell function in HIV+ individuals

AIDS (London), 2019-03, Vol.33 (4), p.605-613

2019

Volltextzugriff (PDF)

Neratinib decreases pro-survival responses of [sorafenib + vorinostat] in pancreatic cancer

Biochemical pharmacology, 2020-08, Vol.178, p.114067-114067, Article 114067

2020

Volltextzugriff (PDF)

Ketogenic Diet Alters the Epigenetic and Immune Landscape of Prostate Cancer to Overcome Resistance to Immune Checkpoint Blockade Therapy

Cancer research (Chicago, Ill.), 2024-05, Vol.84 (10), p.1597-1612

2024

Volltextzugriff (PDF)

Neurotoxicity with high-dose disulfiram and vorinostat used for HIV latency reversal

AIDS (London), 2022-01, Vol.36 (1), p.75-82

2022

Volltextzugriff (PDF)

Phase I study of vorinostat with gefitinib in BIM deletion polymorphism/epidermal growth factor receptor mutation double‐positive lung cancer

Cancer science, 2020-02, Vol.111 (2), p.561-570

2020

Volltextzugriff (PDF)

Targeting the arginine metabolic brake enhances immunotherapy for leukaemia

International journal of cancer, 2019-10, Vol.145 (8), p.2201-2208

2019

Volltextzugriff (PDF)

Synergistic antitumour activity of HDAC inhibitor SAHA and EGFR inhibitor gefitinib in head and neck cancer: a key role for ΔNp63α

British journal of cancer, 2019-03, Vol.120 (6), p.658-667

2019

Volltextzugriff (PDF)

Sensitizing Triple Negative Breast Cancer to Tamoxifen Chemotherapy via a Redox-Responsive Vorinostat-containing Polymeric Prodrug Nanocarrier

Theranostics, 2020-01, Vol.10 (6), p.2463-2478

2020

Volltextzugriff (PDF)

Phase I Study of Sorafenib and Vorinostat in Advanced Hepatocellular Carcinoma

American journal of clinical oncology, 2019-08, Vol.42 (8), p.649-654

2019

Volltextzugriff (PDF)

Vorinostat, a histone deacetylase inhibitor, ameliorates the sociability and cognitive memory in an Ash1L-deletion-induced ASD/ID mouse model

Neuroscience letters, 2021-11, Vol.764, p.136241-136241, Article 136241

2021

Volltextzugriff (PDF)

Safety and efficacy of vorinostat, bortezomib, doxorubicin and dexamethasone in a phase I/II study for relapsed or refractory multiple myeloma (VERUMM study: vorinostat in elderly, relapsed and unfit multiple myeloma)

Haematologica (Roma), 2018-10, Vol.103 (10), p.e473-e479

2018

Volltextzugriff (PDF)

A phase 1 trial of Vorinostat in combination with concurrent chemoradiation therapy in the treatment of advanced staged head and neck squamous cell carcinoma

Investigational new drugs, 2019-08, Vol.37 (4), p.702-710

2019

Volltextzugriff (PDF)

Optimization of Epigenetic Modifier Drug Combination for Synergistic Effect against Glioblastoma Multiform Cancer Cell Lines

Cancer investigation, 2024-04, Vol.42 (4), p.319-332

2024

Volltextzugriff (PDF)

Combinatorial antitumor effects of amino acids and epigenetic modulations in hepatocellular carcinoma cell lines

Naunyn-Schmiedeberg's archives of pharmacology, 2021-11, Vol.394 (11), p.2245-2257

2021

Volltextzugriff (PDF)

Primary Rod and Cone Degeneration Is Prevented by HDAC Inhibition

Advances in experimental medicine and biology, 2018, Vol.1074, p.367-373

2018

Volltextzugriff (PDF)

Epigenetic regulation of intestinal peptide transporter PEPT1 as a potential strategy for colorectal cancer sensitization

Cell death & disease, 2021-05, Vol.12 (6), p.532-15, Article 532

2021

Volltextzugriff (PDF)

Vorinostat (SAHA) May Exert Its Antidepressant-Like Effects Through the Modulation of Oxidative Stress Pathways

Neurotoxicity research, 2021-04, Vol.39 (2), p.170-181

2021

Volltextzugriff (PDF)

Bortezomib, Vorinostat, and Dexamethasone Combination Therapy in Relapsed Myeloma: Results of the Phase 2 MUK four Trial

Clinical lymphoma, myeloma and leukemia, 2021-03, Vol.21 (3), p.154-161.e3

2021

Volltextzugriff (PDF)

Novel SAHA‑bendamustine hybrid NL‑101 in combination with daunorubicin synergistically suppresses acute myeloid leukemia

Oncology reports, 2020-07, Vol.44 (1), p.273-282

2020

Volltextzugriff (PDF)

Light-Trigerred Cellular Epigenetic Molecule Release To Reverse Tumor Multidrug Resistance

Bioconjugate chemistry, 2018-04, Vol.29 (4), p.1344-1351

2018

Volltextzugriff (PDF)

Redox-sensitive iodinated polymersomes carrying histone deacetylase inhibitor as a dual-functional nano-radiosensitizer for enhanced radiotherapy of breast cancer

Drug delivery, 2021-01, Vol.28 (1), p.2301-2309

2021

Volltextzugriff (PDF)

1 – 25 von 177

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(167)
Mit Volltextzugriff
(158)

Publikationsform

Artikel
(177)

Sprache

Englisch
(176)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(162)
Life Sciences & Biomedicine
(158)
Vorinostat
(151)
Humans
(141)
Hydroxamic Acids - Administration & Dosage
(88)
Oncology
(85)
Animals
(73)
Histone Deacetylase Inhibitors - Administration & Dosage
(61)
Cell Line, Tumor
(57)
Mice
(55)
Female
(53)
Male
(51)
Hydroxamic Acids - Pharmacology
(48)
Histone Deacetylase Inhibitors - Pharmacology
(44)
Pharmacology & Pharmacy
(42)
Drug Synergism
(41)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(40)
Dosage And Administration
(36)
Vorinostat - Administration & Dosage
(36)
Apoptosis - Drug Effects
(35)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial

Late autophagy inhibitor chloroquine improves efficacy of the histone deacetylase inhibitor SAHA and temozolomide in gliomas

Development of New Nanoniosome Carriers for Vorinostat: Evaluation of Anticancer Efficacy In Vitro

Epigenetic inhibition assisted chemotherapeutic treatment of lung cancer based on artificial exosomes

In-vivo administration of histone deacetylase inhibitors does not impair natural killer cell function in HIV+ individuals

Neratinib decreases pro-survival responses of [sorafenib + vorinostat] in pancreatic cancer

Ketogenic Diet Alters the Epigenetic and Immune Landscape of Prostate Cancer to Overcome Resistance to Immune Checkpoint Blockade Therapy

Neurotoxicity with high-dose disulfiram and vorinostat used for HIV latency reversal

Phase I study of vorinostat with gefitinib in BIM deletion polymorphism/epidermal growth factor receptor mutation double‐positive lung cancer

Targeting the arginine metabolic brake enhances immunotherapy for leukaemia

Synergistic antitumour activity of HDAC inhibitor SAHA and EGFR inhibitor gefitinib in head and neck cancer: a key role for ΔNp63α

Sensitizing Triple Negative Breast Cancer to Tamoxifen Chemotherapy via a Redox-Responsive Vorinostat-containing Polymeric Prodrug Nanocarrier

Phase I Study of Sorafenib and Vorinostat in Advanced Hepatocellular Carcinoma

Vorinostat, a histone deacetylase inhibitor, ameliorates the sociability and cognitive memory in an Ash1L-deletion-induced ASD/ID mouse model

Safety and efficacy of vorinostat, bortezomib, doxorubicin and dexamethasone in a phase I/II study for relapsed or refractory multiple myeloma (VERUMM study: vorinostat in elderly, relapsed and unfit multiple myeloma)

A phase 1 trial of Vorinostat in combination with concurrent chemoradiation therapy in the treatment of advanced staged head and neck squamous cell carcinoma

Optimization of Epigenetic Modifier Drug Combination for Synergistic Effect against Glioblastoma Multiform Cancer Cell Lines

Combinatorial antitumor effects of amino acids and epigenetic modulations in hepatocellular carcinoma cell lines

Primary Rod and Cone Degeneration Is Prevented by HDAC Inhibition

Epigenetic regulation of intestinal peptide transporter PEPT1 as a potential strategy for colorectal cancer sensitization

Vorinostat (SAHA) May Exert Its Antidepressant-Like Effects Through the Modulation of Oxidative Stress Pathways

Bortezomib, Vorinostat, and Dexamethasone Combination Therapy in Relapsed Myeloma: Results of the Phase 2 MUK four Trial

Novel SAHA‑bendamustine hybrid NL‑101 in combination with daunorubicin synergistically suppresses acute myeloid leukemia

Light-Trigerred Cellular Epigenetic Molecule Release To Reverse Tumor Multidrug Resistance

Redox-sensitive iodinated polymersomes carrying histone deacetylase inhibitor as a dual-functional nano-radiosensitizer for enhanced radiotherapy of breast cancer

Aktive Filter

Suchergebnisse filtern